CheckMyRecalls

Medtronic Neuromodulation recalls A820 myPTM Software Application…

Medtronic Neuromodulation recalls A820 myPTM Software Application associated with Medtronic SynchroMe…

Published
9 Apr 2025
Units affected
4365 units
Agency
FDA
Country
United States

The hazard

Product complaints were received describing the A820 myPTM app taking longer than expected for patients to interact with their implantable pump.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.

  • Check the model and lot or serial number on the device label.
  • Speak to your doctor or the clinic that supplied the device before stopping use.
Read the official FDA notice

Product details

A820 myPTM Software Application associated with Medtronic SynchroMed Pump and Infusion System.

Brand / company
Medtronic Neuromodulation
Codes / lots
version v.2x, UDI/DI 00763000632793
Distribution
Worldwide distribution - US Nationwide and the countries of Austria, Belgium, Canary Islands, Czech Republic, France, Germany, Greece, Ireland, Italy, Netherlands, Norway, Portugal, Puerto Rico, Spain, Sweden, Switzerland, United Kingdom.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 9 Apr 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.